Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCL

2.

Report: Breast cancer mortality continues three decade decline, but steeper increases in incidence for some women

3.

PSA Screening May Modestly Curb Prostate Cancer Deaths

4.

Improved end-of-life conversations for cancer patients are identified by a new study.

5.

Enhanced CAR T cell therapy offers new strategy for lymphoma


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot